ArticleJAMA internal medicine2024

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Fasiha Kanwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.